Washington Cannabis: $3.04/g Blended, 100% Capture, and an Oversupply That Feeds Its Own Gray Market

Washington legalized adult-use cannabis in 2012 alongside Colorado and is now the clearest case study in what a mature, oversupplied, commodity-floor market looks like. FY2025 legal sales of roughly $1.18 billion against an estimated 387.6 million grams of resident demand work out to a blended all-products price of about $3.04 per gram and effectively complete resident capture. The 45-47% "illicit gap" in official state models isn't a black market the legal channel failed to displace — it's partly inflated demand assumptions, and partly real surplus that appears available for upstream diversion to prohibition states where it's worth multiples. It never reaches a Washington register, which is part of why the official models can't see it.

Market Overview

Washington voters passed Initiative 502 in November 2012, and the first retail stores opened in July 2014; medical and recreational systems merged in 2016 under the Liquor and Cannabis Board (LCB). More than a decade in, it's a textbook mature market: revenue peaked in 2021 and has fallen every year since as price compression outpaced volume growth — the trajectory the framework predicts once a market reaches full resident capture.

Key metrics:

• ~$1.18B in FY2025 legal sales (back-calculated from cannabis excise collections; cross-validated against independently reported figures)
• $3.04/g blended all-products price (FY2025 sales ÷ framework resident demand of ~387.6M grams)
• 100% estimated legal market capture of resident demand
• 473 active retail licenses, ~986 producer/producer-processor, ~1,039 processor (Whitney Economics / LCB, as of May 2024)
• 37% excise tax on retail (RCW 69.50.535) — among the highest cannabis excise rates in the nation — plus state and local sales tax; effective consumer rate ~44-50%
• Medical patients exempt from the excise since June 6, 2024 (HB 1453)
• Adults 21+: ~5.9 million (U.S. Census Bureau, 2024)
• Adult-use home cultivation prohibited — one of the few adult-use states with no personal-grow allowance (medical patients may still cultivate); the economics rarely favor home grow anyway at a dollar a gram
• No major MSO presence — a compliance signal, not a margin one, common to the most oversupplied markets

Flower Pricing

At $3.04 per gram blended across all categories, Washington sits at the commodity floor beside Michigan ($2.96) and just below Colorado ($3.18) — the cluster where oversupply and cultivator competition have driven prices to the natural endpoint of an agricultural commodity. Grams of bud sell for roughly a dollar, ounces for $29-50. There's no prohibition premium left, and no illicit operator can meaningfully undercut a regulated store selling tested product at commodity prices.

The state's own consumer data confirms the rank while overstating the level. The 2025 International Cannabis Policy Study (ICPS) found Washington among the lowest-priced jurisdictions surveyed — $6.65/g overall and $5.65/g from legal sources, against a US legal-state category average of $7.73 and a US figure of $8.02. That self-reported legal figure runs above $3.04 because respondents anchor on the sticker price of their last purchase, not the gram-weighted reality; heavy daily users buying discounted bulk, who drive most of the volume, are underweighted. The gap is menu inflation, quantified — but the direction holds: Washington is among the cheapest legal markets in the country.

*Washington's $3.04 is an all-products-blended figure; the other states shown are flower-average pricing and are not directly comparable.

Tax Structure

Washington carries one of the highest cannabis excise taxes in the nation — 37% on retail sales (RCW 69.50.535), excluded from the sales-tax base, with state and local sales tax (6.5% + 0-3.9%) stacked on top for an effective consumer burden near 44-50%. (Some wholesale or weight-based structures, like Alaska's, can run higher on certain measures.) Medical patients have been excise-exempt since June 6, 2024 (HB 1453). That a state with one of the highest excise taxes also posts one of the lowest blended prices is the framework's thesis in one data point: supply, not tax, sets the price once a market is genuinely supplied. The tax landed on a market so oversupplied that prices hit the floor anyway, and consumers converted to legal regardless because the illicit alternative had no economics left.

Total Addressable Market

Washington's adult population 21+ is approximately 5.9 million. Applying the framework's validated consumption baseline of 18% participation at 1.0 gram per day:

• 5,900,000 adults 21+
• 1,062,000 estimated regular consumers (18%)
• 387.6 million grams annual resident demand (1.062M × 365)
• TAM at $3.04/g: ~$1.18B

Against ~$1.18 billion in FY2025 legal sales:

Washington's estimated legal market capture rate: 100%.

These figures are derived — the framework's demand model (18% participation × 1.0 g/day × adults 21+) divided into reported sales — not regulatory reporting. Washington publishes excise revenue, not gram-level sales, so no official source reports a blended price or capture rate at all; the $3.04 follows from the framework's premise that legal sales now equal resident demand in a market this mature.

This is where the state's own models break. Whitney Economics put legal participation at 53-55%; the JLARC/RAND study put it at 60-70%. They don't agree with each other, and both rest on per-capita consumption assumptions well above the validated 1.0 g/day baseline — the inflated figure that closed legal systems have repeatedly contradicted. Correct the baseline and the phantom demand evaporates. With no usable seed-to-sale data since 2017, every one of these estimates is modeled, not measured.

The consumer data shows full resident capture. ICPS 2025 found Washington consumers sourcing from a store at among the highest rates of any jurisdiction — 74%, versus 48% in illegal states — and from a dealer at among the lowest, just 15%. In-state illicit retail appears small relative to legal retail and increasingly hard to justify on price: at floor prices, a dealer has little left to compete on.

Revenue Trend

Cumulative cannabis account revenue tops $4.26 billion, 98.7% of it excise tax. The peak-then-decline shape isn't failure — it's a market that finished converting resident demand and now sells more grams for fewer dollars as prices compress, the same arc Colorado, Oregon, and Nevada traced.

Dispensary Density

Washington's 473 retail licenses against 5.9 million adults give a density of 8.0 stores per 100,000 — well above the 3-4 threshold below which access starts to suppress capture. Revenue per store runs about $2.49 million, which Whitney Economics found ranks 23rd nationally, near the U.S. average. The count is capped (new retail now flows mainly through the Social Equity Program), but that hasn't strangled capture — the existing network plus pre-order pickup already reaches the resident base. The constraint that defines Washington isn't retail density; it's cultivation oversupply.

Where the Oversupply Goes

If the resident market is fully captured at a floor price, where does the excess production go? Not a thriving in-state black market — at a dollar a gram, no unlicensed seller can compete. A portion of the surplus appears available for upstream diversion, at the cultivator and processor tier, before it's ever recorded as a legal sale — moved to prohibition states where it commands several times the price. JLARC's consultant estimated 2023 production ran two to three times higher than licensed retail sales, and the state's research arm anticipated the dynamic: a 2019 Washington State Institute for Public Policy report noted that legal cultivation is cheaper and safer than covert production, so when legal product fetches more in a prohibition market there's a standing incentive to divert — and that "masking," the difficulty of distinguishing illicit grows from licensed ones, actually favors cultivation in legal states for export.

LCB enforcement shows the mechanism in action. In December 2025 the LCB summarily suspended producer/processor Wingsing LLC after an investigation found alleged diversion to illicit markets, grow operations not listed on the license, and significant discrepancies between physical inventory and CCRS traceability records. A December 2024 action against a Tacoma producer involved over 7,000 plants not properly recorded; a 2022 case saw roughly 5,000 plants seized amid traceability violations and probable diversion. These aren't retail transactions gone astray — they're product that never properly entered the counted economy. It's the signature of capacity available for export: logged as destroyed, grown off-book, or moved straight to unlicensed hands. That's a plausible account of how licensed capacity far above resident demand persists without a visible legal glut — much of the excess was never going to be rung up in Washington.

What the CHS Literature Missed

Washington's LCB Research Program studied cannabinoid hyperemesis syndrome (CHS) in-state with population data — a February 2025 data brief by Glodosky, Okey, and Watson — and the findings cut against the panic framing. In a weighted sample of past-year users, those who used any illegal-sourced cannabis accounted for 76% of CHS cases versus 24% for legal-only users, and in the adjusted model greater legal sourcing was a statistically significant protective factor. There was no difference in flower-use frequency between CHS cases and non-cases; the signal tracked vapes, concentrates, and edibles. And the apparent link to overall use frequency lost significance once sex and illegal sourcing were controlled.

Read honestly, the state's own data points away from "legal cannabis is driving a CHS epidemic" — the signal tracked illegal sourcing and higher-frequency use of vapes, concentrates, and edibles, not flower frequency. The brief itself cautions that CHS cases were few and more research is needed. ICPS corroborates the small scale: only 11% of past-year consumers sought medical help for any adverse event of any kind, of which CHS is a fraction. That's consistent with population-level analysis showing actual prevalence far below the figures drawn from emergency-department samples of self-selected heavy users.

The Bottom Line

Washington is the mature-market endgame made visible: one of the highest excise taxes in the country paired with one of the lowest blended prices — $3.04 per gram — because supply, not tax, sets the price once a market is genuinely supplied. Resident capture is effectively complete, and the sub-100% figures in the state's own models are artifacts of an inflated consumption baseline and modeling done without seed-to-sale data since 2017.

What looks like a persistent illicit market is something those models can't see: surplus that appears available for upstream diversion, before any legal sale, and moved toward prohibition states where prices stay high. In-state illicit retail looks small relative to legal retail and hard to justify on price — at a dollar a gram, a dealer has little to compete on. What happens next turns not on tax, density, or retail enforcement, but on whether the state can track a cultivation sector licensed to produce far more than its own market will ever absorb.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.